Total submissions: 28
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000167825 | SCV000073571 | benign | Hereditary breast and ovarian cancer syndrome | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000031751 | SCV000154095 | likely benign | Breast-ovarian cancer, familial 2 | 2014-04-08 | criteria provided, single submitter | literature only | |
Gene |
RCV000152885 | SCV000167412 | benign | not specified | 2014-01-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000131022 | SCV000185950 | benign | Hereditary cancer-predisposing syndrome | 2014-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Michigan Medical Genetics Laboratories, |
RCV000031751 | SCV000196016 | benign | Breast-ovarian cancer, familial 2 | 2014-11-03 | criteria provided, single submitter | clinical testing | |
EGL Genetic Diagnostics, |
RCV000152885 | SCV000202304 | likely benign | not specified | 2014-05-01 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000735613 | SCV000219411 | likely benign | Breast and/or ovarian cancer | 2019-04-18 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000167825 | SCV000267847 | likely benign | Hereditary breast and ovarian cancer syndrome | 2016-04-25 | criteria provided, single submitter | clinical testing | |
Illumina Clinical Services Laboratory, |
RCV000371112 | SCV000383788 | likely benign | Fanconi anemia, complementation group D1 | 2018-02-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Clinical Services Laboratory, |
RCV000031751 | SCV000383789 | likely benign | Breast-ovarian cancer, familial 2 | 2018-02-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Integrated Genetics/Laboratory Corporation of America | RCV000167825 | SCV000494364 | benign | Hereditary breast and ovarian cancer syndrome | 2014-09-29 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000152885 | SCV000538491 | uncertain significance | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ClinVar: 10 labs classify as LB/Ben; ExAC: 0.1% (94/66682) European chromosomes |
Cancer Genetics and Genomics Laboratory, |
RCV000152885 | SCV000586982 | benign | not specified | 2017-04-19 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000152885 | SCV000592209 | benign | not specified | 2012-03-09 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001282957 | SCV000602794 | benign | none provided | 2020-06-26 | criteria provided, single submitter | clinical testing | |
Color Health, |
RCV000131022 | SCV000683983 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000031751 | SCV000743349 | benign | Breast-ovarian cancer, familial 2 | 2014-10-09 | criteria provided, single submitter | clinical testing | |
DNA and Cytogenetics Diagnostics Unit, |
RCV000031751 | SCV000744542 | benign | Breast-ovarian cancer, familial 2 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000131022 | SCV000747808 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000034464 | SCV000805782 | likely benign | not provided | 2017-08-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000034464 | SCV001148998 | likely benign | not provided | 2021-01-01 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034464 | SCV000043231 | probably not pathogenic | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Likely benign. |
Sharing Clinical Reports Project |
RCV000031751 | SCV000054359 | benign | Breast-ovarian cancer, familial 2 | 2012-05-01 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000031751 | SCV000147403 | benign | Breast-ovarian cancer, familial 2 | 2002-05-29 | no assertion criteria provided | clinical testing | |
Pathway Genomics | RCV000031751 | SCV000207353 | likely benign | Breast-ovarian cancer, familial 2 | 2014-11-06 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000031751 | SCV000733319 | benign | Breast-ovarian cancer, familial 2 | no assertion criteria provided | clinical testing | ||
True Health Diagnostics | RCV000131022 | SCV000787955 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-14 | no assertion criteria provided | clinical testing | |
Foulkes Cancer Genetics LDI, |
RCV000735613 | SCV000863751 | uncertain significance | Breast and/or ovarian cancer | 2001-08-16 | no assertion criteria provided | clinical testing |